Bill
Bill > HB136
summary
Introduced
01/04/2022
01/04/2022
In Committee
03/29/2022
03/29/2022
Crossed Over
03/18/2022
03/18/2022
Passed
Dead
04/14/2022
04/14/2022
Introduced Session
2022 Regular Session
Bill Summary
Create various new sections of KRS 218A to define terms and establish a medicinal cannabis program; create a new section of KRS Chapter 138 to establish an excise tax on certain transfers of medicinal cannabis; amend KRS 139.470 to exempt the sale of medical cannabis from the state sales tax; amend KRS 138.870 to exempt medicinal cannabis from the excise tax on controlled substances; amend KRS 216B.402 to require hospital emergency departments to report cases of cannabinoid hyperemesis syndrome to the Department for Public Health; amend KRS 218A.010, 218A.1421, 218A.1422, and 218A.1423 to conform; amend KRS 218A.202 to require the Department for Public Health to utilize the electronic system for monitoring controlled substances to monitor medicinal cannabis; amend 218A.500 to conform; amend KRS 342.815 to establish that the Employer’s Mutual Insurance Authority shall not be required to provide coverage to an employer if doing so would subject the authority to a violation of state or federal law; some sections EFFECTIVE July 1, 2023; APPROPRIATION.
AI Summary
This bill creates a medicinal cannabis program in Kentucky. The key provisions are:
- It defines various terms related to the medicinal cannabis program, including "medicinal cannabis," "cardholder," and "cannabis business."
- It establishes a Division of Medicinal Cannabis within the Department for Public Health to oversee and regulate the program.
- It allows for the legal use of medicinal cannabis by registered qualified patients, visiting qualified patients, and designated caregivers, and provides protections from prosecution for these individuals and certain professionals.
- It requires individuals to obtain a registry identification card to use medicinal cannabis.
- It creates a licensure system for cannabis businesses, including cultivators, dispensaries, processors, producers, and safety compliance facilities.
- It imposes an excise tax on the sale of medicinal cannabis and creates two related trust funds to fund administration of the program and provide grants.
- It exempts the sale of medicinal cannabis from state sales tax and the excise tax on controlled substances.
- It requires hospitals to report cases of cannabinoid hyperemesis syndrome involving registered patients.
- Some sections take effect on July 1, 2023, while others are effective upon passage.
Committee Categories
Health and Social Services, Justice
Sponsors (43)
Jason Nemes (R)*,
Tina Bojanowski (D),
Kevin Bratcher (R),
George Brown (D),
Thomas Burch (D),
McKenzie Cantrell (D),
Jonathan Dixon (R),
Jeffery Donohue (D),
Daniel Elliott (R),
Patrick Flannery (R),
Ken Fleming (R),
Chris Freeland (R),
Al Gentry (D),
Jim Gooch (R),
Derrick Graham (D),
Mark Hart (R),
Angie Hatton (D),
Samara Heavrin (R),
Thomas Huff (R),
Joni Jenkins (D),
Norma Kirk-McCormick (R),
Matt Koch (R),
Nima Kulkarni (D),
William Lawrence (R),
Derek Lewis (R),
Savannah Maddox (R),
D. Chad McCoy (R),
Charles Miller (D),
Jerry Miller (R),
Patti Minter (D),
David Osborne (R),
Ruth Ann Palumbo (D),
Phillip Pratt (R),
Felicia Rabourn (R),
Josie Raymond (D),
Rachel Roberts (D),
Tom Smith (R),
Cherlynn Stevenson (D),
Pamela Stevenson (D),
Killian Timoney (R),
Susan Westrom (D),
Charles Wheatley (D),
Lisa Willner (D),
Last Action
to Health & Welfare (S) (on 03/29/2022)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...